Day Zero Diagnostics Awarded $300K SBIR Grant for Fecal Microbiota Transplant Assay
August 29 2023
Day Zero Diagnostics receives SBIR Grant for Development of Microbiome Diagnostics.
Read More
Sequencing-Based Diagnostics Critical to Fighting Against Infectious Disease
November 9 2022
Listen to our Co-founder & CEO, Jong Lee, speak with ICT Magazine about the critical role of Sequencing-Based Diagnostics in the fight against infectious disease.
Read More
Day Zero Diagnostics Appoints Gail Marcus to its Board
November 9 2022
Day Zero Diagnostics appoints Gail Marcus to its Board of Directors as an independent director.
Read More